Nisa Investment Advisors’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
FP
RCM
MG
Nisa Investment Advisors's SANA Position: Q2 2026 in Review
Nisa Investment Advisors increased its Sana Biotechnology (SANA) stake by 6.2% in Q2 2026, buying an estimated $2.03K and bringing the position to 10,731 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1968.
Nisa Investment Advisors first reported a position in SANA in Q4 2021 and has held it in 19 quarters since. The position peaked at $41.1K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.
- Nisa Investment Advisors held 10,731 shares of Sana Biotechnology worth $37.5K as of Q2 2026.
- Nisa Investment Advisors bought 630 Sana Biotechnology shares in Q2 2026, an estimated $2.03K.
- Sana Biotechnology made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1968 holding.
- Nisa Investment Advisors first reported a position in Sana Biotechnology in Q4 2021 and has held it in 19 quarters since.
- Nisa Investment Advisors's Sana Biotechnology position peaked at $41.1K in Q4 2025.
- 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.